Literature DB >> 35455969

N-VEGF, the Autoregulatory Arm of VEGF-A.

Marina Katsman1, Aviva Azriel1, Guy Horev2, Yitzhak Reizel1, Ben-Zion Levi1.   

Abstract

Vascular endothelial growth factor A (VEGF-A) is a secreted protein that stimulates angiogenesis in response to hypoxia. Under hypoxic conditions, a non-canonical long isoform called L-VEGF is concomitantly expressed with VEGF-A. Once translated, L-VEGF is proteolytically cleaved to generate N-VEGF and VEGF-A. Interestingly, while VEGF-A is secreted and affects the surrounding cells, N-VEGF is mobilized to the nucleus. This suggests that N-VEGF participates in transcriptional response to hypoxia. In this study, we performed a series of complementary experiments to examine the functional role of N-VEGF. Strikingly, we found that the mere expression of N-VEGF followed by its hypoxia-independent mobilization to the nucleus was sufficient to induce key genes associated with angiogenesis, such as Hif1α,VEGF-A isoforms, as well as genes associated with cell survival under hypoxia. Complementarily, when N-VEGF was genetically depleted, key hypoxia-induced genes were downregulated and cells were significantly susceptible to hypoxia-mediated apoptosis. This is the first report of N-VEGF serving as an autoregulatory arm of VEGF-A. Further experiments will be needed to determine the role of N-VEGF in cancer and embryogenesis.

Entities:  

Keywords:  VEGF-A; angiogenesis; hypoxia

Mesh:

Substances:

Year:  2022        PMID: 35455969      PMCID: PMC9024919          DOI: 10.3390/cells11081289

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   7.666


  38 in total

1.  Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosome.

Authors:  H Cohen; A Azriel; T Cohen; D Meraro; S Hashmueli; D Bech-Otschir; R Kraft; W Dubiel; B Z Levi
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 2.  Mechanisms of Notch signaling: a simple logic deployed in time and space.

Authors:  Domingos Henrique; François Schweisguth
Journal:  Development       Date:  2019-02-01       Impact factor: 6.868

3.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

Review 4.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

5.  miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

Authors:  Mary Ann Thompson; Mick D Edmonds; Shan Liang; Sara McClintock-Treep; Xuan Wang; Shaoying Li; Christine M Eischen
Journal:  Hum Pathol       Date:  2015-11-30       Impact factor: 3.466

Review 6.  60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides.

Authors:  Niamh X Cawley; Zhaojin Li; Y Peng Loh
Journal:  J Mol Endocrinol       Date:  2016-02-15       Impact factor: 5.098

7.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

Review 8.  VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level.

Authors:  Tania Arcondéguy; Eric Lacazette; Stefania Millevoi; Hervé Prats; Christian Touriol
Journal:  Nucleic Acids Res       Date:  2013-07-12       Impact factor: 16.971

9.  Brain injury induces HIF-1α-dependent transcriptional activation of LRRK2 that exacerbates brain damage.

Authors:  Yun-Hee Bae; Hyejin Joo; Jinhyun Bae; Seung Jae Hyeon; Song Her; Eunhwa Ko; Hwan Geun Choi; Hoon Ryu; Eun-Mi Hur; Youngmin Bu; Byoung Dae Lee
Journal:  Cell Death Dis       Date:  2018-11-12       Impact factor: 8.469

10.  Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma.

Authors:  Yuzo Yamazato; Atsushi Shiozaki; Daisuke Ichikawa; Toshiyuki Kosuga; Katsutoshi Shoda; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Yoshinori Marunaka; Eigo Otsuji
Journal:  Oncotarget       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.